Healthy volunteers help uncover drug interactions
NCT ID NCT07222098
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 35 times
Summary
This study looked at how a single dose of an experimental drug, MK-1084, changes the way the body processes two common medications: rosuvastatin (for cholesterol) and metformin (for diabetes). Sixteen healthy adults took part in a crossover design where each person received the medications with and without MK-1084. The goal was to measure drug levels in the blood over time to see if there is an interaction.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Celerion ( Site 0001)
Lincoln, Nebraska, 68502, United States
Conditions
Explore the condition pages connected to this study.